Research on the Motivation and Countermeasures of Financial Fraud of Listed Companies—Taking Kangmei Pharmaceutical as an Example

Authors

  • Junli Wang Beijing City University Author
  • Haofeng Xu Beijing City University Author

DOI:

https://doi.org/10.71204/y2gzjp13

Keywords:

GONE Theory, Kangmei Pharmaceutical, Financial Fraud

Abstract

Kangmei Pharmaceutical fell into crisis due to the exposure of its financial fraud. Its fraudulent behavior not only damaged the company's reputation but also caused huge losses to investors. It also provided a background for studying the motives and countermeasures of financial fraud in listed companies. Based on the GONE theory, this paper systematically analyzed the motives of Kangmei Pharmaceutical's financial fraud from four factors: greed, opportunity, need, and exposure. It also adopted the literature research method and case analysis method for research and proposed countermeasures such as cultivating an honest corporate culture, optimizing performance assessment and incentive mechanisms, improving the company's internal control mechanism and continuous risk assessment and monitoring in combination with the GONE theory. For enterprises, the significance of studying financial fraud in listed companies lies in promoting self-reflection and improvement. For industry, studying financial fraud in listed companies has the significance of improving the overall regulatory level of the industry. For the country, studying financial fraud in listed companies is of great significance for maintaining financial market stability, protecting investors' rights and interests, and promoting healthy economic development.

References

Chen, X. (2024). Research on the methods and motivations of financial fraud in listed companies: Based on the analysis of 10 cases of fraud in listed companies. Financial Management Research, (09), 59–64.

Lan, C. (2024). Analysis of the causes and countermeasures of financial fraud in listed companies from the perspective of fraud triangle theory: A case study of Longli Biotechnology. National Circulation Economy, (08), 185–188.

Li, Y. (2023). Establishment of financial fraud early warning mechanism based on grey relational degree model and COSO framework: Taking Kangmei Pharmaceutical fraud case as an example. Bohai Rim Economic Outlook, (11), 173–176.

Shen, B. (2023). Analysis of the causes and countermeasures of financial fraud in listed companies: A case study of Longli Biotechnology. National Circulation Economy, (15), 104–107.

Wang, X. (2022). Analysis of the causes and countermeasures of financial fraud in listed companies. Journal of Shaanxi Youth Vocational College, (02), 66–70.

Wang, X. (2024). Analysis of the causes and countermeasures of financial fraud in listed companies: A case study of Pangda Group. National Circulation Economy, (12), 185–188.

Wu, C., & Sun, W. (2024). Research on financial fraud of listed companies based on the fraud triangle theory: A case study of Tongji Tang. Finance and Accounting, (08), 48–50.

Yu, H. (2024). Research on the causes and preventive measures of financial fraud in listed companies: A case study of X Company. China Management Informatization, 27(08), 16–18.

Zhang, X. (2023). Analysis of the causes and countermeasures of financial fraud in listed companies: Taking Kangmei Pharmaceutical as an example. Chinese Market, (11), 143–146.

Downloads

Published

2025-08-26

How to Cite

Research on the Motivation and Countermeasures of Financial Fraud of Listed Companies—Taking Kangmei Pharmaceutical as an Example. (2025). Financial Strategy and Management Reviews, 1(2), 1-10. https://doi.org/10.71204/y2gzjp13